 Shares of Vallon Pharmaceuticals Inc. VLON, 96.81 skyrocketed 89.0 on massive volume in morning trading Friday after the biopharmaceutical company said it is exploring strategic alternatives, including a possible sale of the company. Trading volume spiked to 82.8 million shares, compared with the full-day average of about 720,000 shares. 